These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9290621)

  • 21. Carnitine-acylcarnitine translocase deficiency.
    Pande SV
    Am J Med Sci; 1999 Jul; 318(1):22-7. PubMed ID: 10408757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First prenatal diagnosis of the carnitine transporter defect.
    Christodoulou J; Teo SH; Hammond J; Sim KG; Hsu BY; Stanley CA; Watson B; Lau KC; Wilcken B
    Am J Med Genet; 1996 Dec; 66(1):21-4. PubMed ID: 8957505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden infant death from neonate carnitine palmitoyl transferase II deficiency.
    Du SH; Zhang F; Yu YG; Chen CX; Wang HJ; Li DR
    Forensic Sci Int; 2017 Sep; 278():e41-e44. PubMed ID: 28739175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 26. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.
    Rubio-Gozalbo ME; Vos P; Forget PP; Van Der Meer SB; Wanders RJ; Waterham HR; Bakker JA
    Acta Paediatr; 2003 Apr; 92(4):501-4. PubMed ID: 12801121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis.
    Brivet M; Slama A; Ogier H; Boutron A; Demaugre F; Saudubray JM; Lemonnier A
    J Inherit Metab Dis; 1994; 17(3):271-4. PubMed ID: 7807931
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carnitine/acylcarnitine translocase deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):403-4. PubMed ID: 9590083
    [No Abstract]   [Full Text] [Related]  

  • 30. Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.
    Galron D; Birk OS; Kazanovitz A; Moses SW; Hershkovitz E
    J Inherit Metab Dis; 2004; 27(2):267-73. PubMed ID: 15159657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation.
    Rinaldo P; Matern D
    Genet Med; 2000; 2(6):338-44. PubMed ID: 11339654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnic-specific splicing mutation of the carnitine-acylcarnitine translocase gene in a Chinese neonate presenting with sudden unexpected death.
    Lam CW; Lai CK; Chow CB; Tong SF; Yuen YP; Mak YF; Chan YW
    Chin Med J (Engl); 2003 Jul; 116(7):1110-2. PubMed ID: 12890396
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional analysis of mutant human carnitine acylcarnitine translocases in yeast.
    IJlst L; van Roermund CW; Iacobazzi V; Oostheim W; Ruiter JP; Williams JC; Palmieri F; Wanders RJ
    Biochem Biophys Res Commun; 2001 Jan; 280(3):700-6. PubMed ID: 11162577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver.
    Boles RG; Martin SK; Blitzer MG; Rinaldo P
    Hum Pathol; 1994 Aug; 25(8):735-41. PubMed ID: 8056418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carnitine-acylcarnitine translocase deficiency caused by
    Zhang L; Hu Y; Xie M; Zhang Y; Cen K; Chen L; Cui Y; Li H; Wang D
    J Int Med Res; 2023 Apr; 51(4):3000605231163811. PubMed ID: 37115522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report.
    Thanka J; Padmasani ; Krishnan L; Kuruvilla S
    Indian J Pathol Microbiol; 2005 Oct; 48(4):485-7. PubMed ID: 16366103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carnitine acylcarnitine translocase deficiency].
    Kimura M; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():714-6. PubMed ID: 12013981
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.
    Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N
    Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.